SCHEMBL4436696

SCHEMBL4436696

NCCCC(=O)NCc1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.79
MEN1 O00255 2/20 0.77
KMT2A Q03164 2/20 0.77
EPHX2 P34913 3/20 0.66
TPSAB1 Q15661 2/20 0.64
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
TRPV1 Q8NER1 1/20 0.62
LMNA P02545 1/20 0.60
CYP3A4 P08684 2/20 0.60
HTT P42858 1/20 0.60
ALDH1A1 P00352 1/20 0.60
KEAP1 Q14145 1/20 0.57
NFE2L2 Q16236 1/20 0.57
FAAH O00519 1/20 0.57
CNR1 P21554 1/20 0.57
CNR2 P34972 1/20 0.57
CYP2C19 P33261 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8499126 0.95 MEN1 (0.80) GAAMEN1KMT2AEPHX2TPSAB1
SCHEMBL14623873 0.93 MEN1 (0.83) GAAMEN1KMT2AEPHX2TPSAB1
SCHEMBL11434850 0.93 MEN1 (0.83) GAAMEN1KMT2AEPHX2TPSAB1
SCHEMBL7353744 0.91 GAA (0.75) GAAMEN1KMT2AEPHX2TPSAB1
Hydrochloric Acid SCHEMBL1128739 0.89 GAA (0.72) GAAMEN1KMT2AEPHX2TPSAB1
SCHEMBL2942358 0.89 MEN1 (0.96) GAAMEN1KMT2AEPHX2TRPV1
SCHEMBL27703735 0.86 MEN1 (0.83) GAAMEN1KMT2AEPHX2TPSAB1
SCHEMBL16153816 0.85 GAA (0.77) GAAMEN1KMT2AEPHX2TPSAB1
SCHEMBL16153817 0.84 GAA (0.71) GAAMEN1KMT2AEPHX2TPSAB1
SCHEMBL8935458 0.84 GAA (0.66) GAAMEN1KMT2ATPSAB1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115400065-A Skin care composition with multiple effects of moisturizing, resisting wrinkles, resisting aging, relieving and repairing and application thereof 珠海市柏瑞医药科技有限公司 2022-11-29 CN disclosed
EP-2439202-B1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 SALVAT LAB SA (ES) 2016-04-20 EP disclosed
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
EP-2120846-A2 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS BASF SE (DE) 2009-11-25 EP disclosed
WO-2008107347-A2 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS BASF SE (CH) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 GAA 751/4885MEN1 827/4885KMT2A 3868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.